跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 章賢
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0003-2134-1309
電子郵件
862077
tmuh.org
tw
h-index
149
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2021
每年研究成果
概覽
指紋
網路
研究成果
(13)
類似的個人檔案
(6)
指紋
查看啟用 Chang-Hsien Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Metabolic Syndrome
100%
Preventive Medicine
94%
Health Care
85%
Medical Examination
71%
Chronic Kidney Disease
57%
Obesity
42%
Diabetes
42%
Systematic Review
42%
Meta-Analysis
42%
Malignant Neoplasm
42%
End Stage Liver Disease
42%
Supplementation
42%
Probiotic Agent
42%
4 Iodo 2,5 Dimethoxyamphetamine
42%
Gestational Diabetes
42%
Biocompatible Material
42%
Intervertebral Disk Degeneration
42%
Neonatal Infant
42%
Birth Weight
42%
Diabetes Mellitus
42%
Electronic Patient Record
42%
Blood Urea Nitrogen
32%
Disease
32%
Chronic Liver Disease
28%
Prothrombin Time
28%
Retrospective Cohort Study
28%
FibroScan
21%
Diagnosis
19%
Logistic Regression Analysis
19%
Body Mass Index
16%
Nucleus Pulposus
14%
In Vitro
14%
Reactive Oxygen Species
14%
Healthcare Practitioner
14%
Mortality Rate
14%
Creatinine
14%
Proportional Hazards Model
14%
Medical Record
14%
Bilirubin
14%
Awareness
14%
Odds Ratio
14%
Healthy Lifestyle
14%
Health Status
14%
Medical Informatics
14%
Telemedicine
14%
Hazard Ratio
14%
Chronic Disease
14%
Clinician
14%
Public Health
14%
Chronic Disorder
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
60%
Tree
57%
Randomized Controlled Trial
52%
Obesity
42%
Biomaterial
42%
Chronic Kidney Failure
42%
End Stage Liver Disease
42%
Malignant Neoplasm
42%
Intervertebral Disk Degeneration
42%
Pregnancy Diabetes Mellitus
42%
Metabolic Syndrome X
42%
Probiotic Agent
42%
Diabetes Mellitus
42%
Urate
42%
Hyperuricemia
42%
Disease
39%
Ureaplasma
32%
Prothrombin
28%
Chronic Liver Disease
28%
Xanthine Oxidase Inhibitor
19%
Adverse Event
19%
Creatinine
14%
Bilirubin
14%
Mortality Rate
14%
C Reactive Protein
14%
Febuxostat
14%
Reactive Oxygen Metabolite
12%
Placebo
9%
Lesinurad
9%
Topiroxostat
9%
Terminalia bellirica
9%
Hemoglobin A1c
7%
Mouse
6%
Neuropathy
6%
Therapeutic Effect
6%
Growth Factor
6%
Streptozotocin
6%
Kidney Disease
6%
Retinopathy
6%
Nicotinamide
6%
Nursing and Health Professions
Metabolic Syndrome X
85%
Medical Examination
52%
Cohort Analysis
51%
Chronic Kidney Failure
42%
Decision Trees
42%
Elastograph
35%
Area under the Curve
16%
Logistic Regression Analysis
14%
Disease
13%
Receiver Operating Characteristic
10%
Random Forest
8%
Hemoglobin A1c
7%
Univariate Analysis
5%
Liver Fibrosis
5%
Non Invasive Procedure
5%
Liver Stiffness
5%
Transient Elastography
5%
Fatty Liver
5%
